AreteMedical

Arete Medical Technologies is a Cambridge-based company founded in 2017, specializing in digital therapeutic devices and software for managing chronic respiratory diseases, particularly asthma and chronic obstructive pulmonary disease (COPD). The company focuses on empowering patients to manage their lung conditions proactively at home, aiming to reduce preventable respiratory deaths. Their flagship product, the Respicorder, is a patented digital health device that allows for daily monitoring of lung function at home. It provides hospital-grade respiratory measurements, enabling early intervention and better disease management. Arete Medical also envisions a broader digital health platform that integrates patient data to support precision medicine and preventative care strategies. Arete Medical primarily serves individuals with severe or unstable chronic lung conditions, as well as healthcare providers who need accurate, real-time respiratory monitoring. The company is committed to transforming disease management through accessible home-based technologies, ultimately striving to eliminate preventable respiratory deaths globally.

• Employees 4